Search research articles
Contact Us
Filters
Showing results (1061-1070 of 1,203) with videos related to
Page
of 121
Sort By:
European Urology Focus
|
May 3, 2022
Diet and Health-related Quality of Life Among Men on Active Surveillance for Early-stage Prostate Cancer: The Men's Eating and Living Study (Cancer and Leukemia Group 70807 [Alliance])
J Kellogg Parsons, David Zahrieh, Devin Patel, et al.
European Urology
|
August 7, 2025
Pathogenic Genomic Alterations in Circulating Tumor DNA Predict Overall Survival in Men with Metastatic Castrate-resistant Prostate Cancer
Susan Halabi, Siyuan Guo, Bin Luo, et al.
European Urology
|
September 10, 2020
Apalutamide and Overall Survival in Prostate Cancer
Matthew R Smith, Fred Saad, Simon Chowdhury, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 13, 2019
Prostate-Specific Membrane Antigen Ligand Positron Emission Tomography in Men with Nonmetastatic Castration-Resistant Prostate Cancer
Wolfgang P Fendler, Manuel Weber, Amir Iravani, et al.
Nature Communications
|
July 30, 2021
An integrated functional and clinical genomics approach reveals genes driving aggressive metastatic prostate cancer
Rajdeep Das, Martin Sjöström, Raunak Shrestha, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 11, 2003
Improvements in quality of life and disease-related symptoms in phase I trials of the selective oral epidermal growth factor receptor tyrosine kinase inhibitor ZD1839 in non-small cell lung cancer and other solid tumors
Patricia M LoRusso, Roy S Herbst, Danny Rischin, et al.
Cancer Letters
|
June 26, 2016
An improved CTC isolation scheme for pairing with downstream genomics: Demonstrating clinical utility in metastatic prostate, lung and pancreatic cancer
Gayatri Premasekharan, Elizabeth Gilbert, Ross A Okimoto, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 5, 2015
Humoral Immune Response against Nontargeted Tumor Antigens after Treatment with Sipuleucel-T and Its Association with Improved Clinical Outcome
Debraj GuhaThakurta, Nadeem A Sheikh, Li-Qun Fan, et al.
JAMA Network Open
|
November 20, 2023
Deficit Accumulation Index and Biological Markers of Aging in Survivors of Childhood Cancer
AnnaLynn M Williams, Jeanne S Mandelblatt, Mingjuan Wang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 26, 2015
Androgen Receptor Gene Aberrations in Circulating Cell-Free DNA: Biomarkers of Therapeutic Resistance in Castration-Resistant Prostate Cancer
Arun A Azad, Stanislav V Volik, Alexander W Wyatt, et al.
Page
of 121
Search research articles
Search
Showing results (1061-1070 of 1,203) with videos related to
Sort By:
Page
of 121
European Urology Focus
|
May 3, 2022
Diet and Health-related Quality of Life Among Men on Active Surveillance for Early-stage Prostate Cancer: The Men's Eating and Living Study (Cancer and Leukemia Group 70807 [Alliance])
J Kellogg Parsons, David Zahrieh, Devin Patel, et al.
European Urology
|
August 7, 2025
Pathogenic Genomic Alterations in Circulating Tumor DNA Predict Overall Survival in Men with Metastatic Castrate-resistant Prostate Cancer
Susan Halabi, Siyuan Guo, Bin Luo, et al.
European Urology
|
September 10, 2020
Apalutamide and Overall Survival in Prostate Cancer
Matthew R Smith, Fred Saad, Simon Chowdhury, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 13, 2019
Prostate-Specific Membrane Antigen Ligand Positron Emission Tomography in Men with Nonmetastatic Castration-Resistant Prostate Cancer
Wolfgang P Fendler, Manuel Weber, Amir Iravani, et al.
Nature Communications
|
July 30, 2021
An integrated functional and clinical genomics approach reveals genes driving aggressive metastatic prostate cancer
Rajdeep Das, Martin Sjöström, Raunak Shrestha, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 11, 2003
Improvements in quality of life and disease-related symptoms in phase I trials of the selective oral epidermal growth factor receptor tyrosine kinase inhibitor ZD1839 in non-small cell lung cancer and other solid tumors
Patricia M LoRusso, Roy S Herbst, Danny Rischin, et al.
Cancer Letters
|
June 26, 2016
An improved CTC isolation scheme for pairing with downstream genomics: Demonstrating clinical utility in metastatic prostate, lung and pancreatic cancer
Gayatri Premasekharan, Elizabeth Gilbert, Ross A Okimoto, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 5, 2015
Humoral Immune Response against Nontargeted Tumor Antigens after Treatment with Sipuleucel-T and Its Association with Improved Clinical Outcome
Debraj GuhaThakurta, Nadeem A Sheikh, Li-Qun Fan, et al.
JAMA Network Open
|
November 20, 2023
Deficit Accumulation Index and Biological Markers of Aging in Survivors of Childhood Cancer
AnnaLynn M Williams, Jeanne S Mandelblatt, Mingjuan Wang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 26, 2015
Androgen Receptor Gene Aberrations in Circulating Cell-Free DNA: Biomarkers of Therapeutic Resistance in Castration-Resistant Prostate Cancer
Arun A Azad, Stanislav V Volik, Alexander W Wyatt, et al.
Page
of 121